Loading...
Indian Pharmaceutical Exporter · #11 for Vaccine · $1.2M export value · DGFT Verified
Bharat Biotech International Ltd is the #11 Indian exporter of Vaccine with $1.2M in export value and 24 verified shipments. Bharat Biotech International Ltd holds a 0.2% market share in Vaccine exports across 14 countries.
| 25 |
| 4.5% |
| GHANA | $1.1M | 23 | 4.4% |
| ZAMBIA | $947.3K | 23 | 3.6% |
| PAKISTAN | $850.0K | 17 | 3.3% |
| THAILAND | $758.9K | 20 | 2.9% |
| BANGLADESH | $750.2K | 16 | 2.9% |
Bharat Biotech International Ltd exports Vaccine to 88 countries. The largest destination is NIGERIA accounting for 12.6% of Bharat Biotech International Ltd's Vaccine shipments, followed by TANZANIA (9.6%) and KENYA (9.4%). These destinations reflect Bharat Biotech International Ltd's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NATIONAL PRIMARY HEALTH CARE | NIGERIA | $2.8M | 57 |
| PERMANENT SECRETARY MINISTRY OF | TANZANIA | $1.8M | 35 |
| NATIONAL VACCINES AND IMMUNIZATION | KENYA | $1.5M | 30 |
| GROUPE TECHNIQUE CENTRAL | CAMEROON | $1.4M | 28 |
| DUC MINH MEDICAL JOINT STOCK COMPAN | VIETNAM, DEMOCRATIC REP. OF | $856.5K | 19 |
| EXPANDED PROGRAM ON IMMUNIZATION | PAKISTAN | $750.0K | 15 |
| MINISTERE DE LA SANTE | MOROCCO | $741.3K | 15 |
| D G CENTRAL MEDICAL STORTES DEPT | BANGLADESH | $700.0K | 14 |
| MINISTERE DE LA SANTE PUBLIQUE | MADAGASCAR | $700.0K | 14 |
| PERMANENT SECRETARY, MINISTRY OF | ZIMBABWE | $700.0K | 14 |
Bharat Biotech International Ltd supplies Vaccine to 173 buyers globally. The largest buyer is NATIONAL PRIMARY HEALTH CARE (NIGERIA), followed by PERMANENT SECRETARY MINISTRY OF (TANZANIA) and NATIONAL VACCINES AND IMMUNIZATION (KENYA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
India exported $313.3M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. Bharat Biotech International Ltd contributes $1.2M to this total, accounting for 0.2% of India's Vaccine exports. Bharat Biotech International Ltd ships Vaccine to 88 countries through 173 buyers.
Bharat Biotech International Ltd's average Vaccine shipment value is $50.0K per consignment, based on 24 shipments totaling $1.2M. The largest destination is NIGERIA (12.6% of Bharat Biotech International Ltd's Vaccine exports).
Bharat Biotech International Ltd ranks #11 among 325 Indian Vaccine exporters with a 0.2% market share. The top 3 exporters are SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($161.3M), BIOLOGICAL E. LIMITED ($43.0M), BHARAT BIOTECH INTERNATIONAL LIMITED ($30.4M). Bharat Biotech International Ltd processed 24 shipments to 14 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ROTAVAC 5 ML ROTAVIRUS VACCINE (LIVE ORA | $2.0M | 40 |
| ROTAVAC 2.5 ML ROTAVIRUS VACCINE (LIVE O | $2.0M | 50 |
| TYPBAR TCV-2.5 ML VIAL (TYPHOID VI CONJUGATE VACCINE) | $868.9K | 21 |
| TYPBAR TCV-2.5 ML VIAL (TYPHOID VI CONJUGATE VACCINE)VLS | $650.5K | 14 |
| ROTAVAC 2.5 ML ROTAVIRUS VACCINE (LIVE ORAL) (FOC DROPPERS 110350 NOS)VLS | $300.0K | 6 |
| BIOPOLIO B1 3 1 0ML BIVALENT TYPE 1 AND3 ORAL POLIOMYELITIS VACCINE BOPV 1 MLVIAL OF 10 DOSES FOC DROPPERS 160000NOS | $200.0K | 4 |
| INDIRAB 0.5 ML ( RABIES VACCINE) 0.5ML & | $183.3K | 4 |
| TYPBAR TCV-2.5 ML VIAL TYPHOID VI CONJUGATE VACCINE | $177.5K | 7 |
| ROTAVAC 5 ML ROTAVIRUS VACCINE LIVE ORAL DROPPERS FOC 13320 NOS | $150.0K | 3 |
| ROTAVAC 2.5ML ROTAVIRUS VACCINE ( LIVE,ORAL ) (FOC DROPPERS 30000 NOS)VLS | $150.0K | 3 |
Bharat Biotech International Ltd exports 361 distinct Vaccine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ROTAVAC 5 ML ROTAVIRUS VACCINE (LIVE ORA with 40 shipments worth $2.0M.
What Bharat Biotech International Ltd must comply with to export Vaccine to its top destination countries
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | SANOFI HEALTHCARE INDIA PRIVATE LIMITED | $3.0M | 60 | 21 | $50.0K |
| 14 | BIOLOGICAL E LTD | $2.3M | 46 | 25 | $50.0K |
| 11 | BHARAT BIOTECH INTERNATIONAL LTD ★ | $1.2M | 24 | 14 | $50.0K |
| 15 | PANACEA BIOTEC LTD | $600.0K | 12 | 9 | $50.0K |
Bharat Biotech International Ltd ranks #11 among 325 Indian Vaccine exporters. Average shipment value of $50.0K compared to the market average of $964.0K. The closest competitors by value are SANOFI HEALTHCARE INDIA PRIVATE LIMITED and BIOLOGICAL E LTD.
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,489 | 24.3% |
| SAHAR AIR | 2,995 | 20.9% |
| Bombay Air | 855 | 6.0% |
| HYDERABAD ACC (INHYD4) | 839 | 5.8% |
| HYDERABAD AIR | 805 | 5.6% |
| DELHI AIR CARGO ACC (INDEL4) | 752 | 5.2% |
| DELHI AIR | 581 | 4.0% |
| AHEMDABAD AIR ACC (INAMD4) | 373 | 2.6% |
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Bharat Biotech International Ltd's Vaccine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Bharat Biotech International Ltd
Company Profile
0 products · $0 total trade · 0 categories
Access shipment-level records, pricing trends, and buyer contacts for Bharat Biotech International Ltd.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current shipment-level data, contact TransData Nexus.